Emergent Biosolutions Inc (EBS)
Depreciation & Amortization
$94.40M
TTM · Period ending: · USD
EBS Depreciation & Amortization
Latest reported$94.40Mperiod ending
Latest reported$94.40Mperiod ending
EBS TTM Depreciation & Amortization ($4.82M → $94.40M)
TTM Depreciation & Amortization
High-resolution chart · PNG
EBS depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 94,400,000 | |
| 93,900,000 | |
| 95,800,000 | |
| 98,300,000 | |
| 101,300,000 | |
| 106,300,000 | |
| 108,800,000 | |
| 112,400,000 | |
| 114,000,000 | |
| 118,400,000 | |
| 125,100,000 | |
| 131,100,000 | |
| 135,300,000 | |
| 146,900,000 | |
| 143,200,000 | |
| 136,800,000 | |
| 137,300,000 | |
| 126,000,000 | |
| 123,800,000 | |
| 123,500,000 | |
| 119,600,000 | |
| 115,000,000 | |
| 114,500,000 | |
| 113,500,000 | |
| 112,400,000 | |
| 112,300,000 | |
| 110,700,000 | |
| 107,894,000 | |
| 92,594,000 | |
| 76,494,000 | |
| 62,194,000 | |
| 49,773,000 | |
| 47,175,000 | |
| 44,706,000 | |
| 42,572,000 | |
| 39,973,000 | |
| 40,556,000 | |
| 39,555,000 | |
| 38,229,000 | |
| 37,631,000 | |
| 35,807,000 | |
| 35,643,000 | |
| 35,335,000 | |
| 34,026,000 | |
| 34,457,000 | |
| 34,150,000 | |
| 32,453,000 | |
| 29,697,000 | |
| 25,880,000 | |
| 21,630,000 | |
| 18,958,000 | |
| 17,065,000 | |
| 14,660,000 | |
| 12,987,000 | |
| 11,197,000 | |
| 10,108,000 | |
| 9,750,000 | |
| 9,493,000 | |
| 9,355,000 | |
| 8,896,000 | |
| 7,858,000 | |
| 6,929,000 | |
| 5,990,000 | |
| 5,342,000 | |
| 5,138,000 | |
| 5,033,000 | |
| 4,999,000 | |
| 5,094,000 | |
| 5,209,000 | |
| 5,145,000 | |
| 4,964,000 | |
| 4,767,000 | |
| 4,747,000 | |
| 4,700,000 | |
| 4,817,000 | |
| 5,047,000 |